When Osage University Partners (OUP) first decided to host a conversation between venture investors on a specific industry sector, one topic clearly presented itself through suggestions from several of our academic partners: venture investment in the medical device sector.
Stacy Enxing Seng has been an integral player in some of the significant start-ups in Medtech. Now a venture partner at Lightstone Ventures, Enxing Seng recalls her decision to be the first employee at ev3 and how that led to her leading the vascular group at Covidien.
Medtech leaders this month gathered at the offices of Fox Rothschild in Minneapolis to begin framing the agenda for the Medtech Conference 2017 scheduled for June 1 at the Loews Minneapolis Hotel.
The last few weeks of 2016 have been an active time in policymaking that had a positive impact on the venture capital industry.
Startup draws Takeda Pharmaceutical Co., Lightstone Ventures as backers
Japanese Big Pharma Takeda and VC Lightstone have come together to launch Cerevance, a new company focused on neuroscience...